AcademyHealth recognizes McGlynn with Distinguished Investigator Award

Thursday, June 28, 2012 12:18 PM

AcademyHealth, a national organization serving the fields of health services, policy research and professionals, has named Elizabeth McGlynn, Ph.D., as the 2012 recipient of its Distinguished Investigator Award.

A high honor in the field of health services research and health policy, the Distinguished Investigator Award recognizes individuals who have made significant and lasting contributions to the field of health services research through scholarship and teaching, advancement of science and methods and leadership.

McGlynn is the director of the Kaiser Permanente Center for Effectiveness & Safety Research, an internationally-known expert in the evaluation of health care quality and a leader in the field of health services research.

"Dr. McGlynn has dedicated her career to helping us understand, measure and evaluate health care quality," said Dr. Lisa Simpson, president and CEO of AcademyHealth. "Her research, leadership and counsel have been critically important to our ability to identify evidence-based strategies to improve care quality and outcomes. She is truly deserving of this high honor from our field."

Among McGlynn’s many contributions to the understanding of the level and appropriateness of U.S. health care is the landmark 2003 study "The Quality of Health Care Delivered to Adults in the United States," which found that, on average, American adults receive about half of recommended care. The study used a new method for evaluating quality that was developed under McGlynn's leadership and garnered significant media attention that contributed to a much broader understanding of the size and nature of the quality problem in the U.S. The research was recognized as the 2004 AcademyHealth Article-of-the-Year.

McGlynn is currently leading efforts to further leverage Kaiser Permanente's research infrastructure and integrated health care system to study the effectiveness and safety of new drugs, devices and therapeutic practices.

Share:          
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs